Jane Street
ANTH

Jane Street’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Jane Street’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,344
Closed -$43K – 3141
2013
Q3 		$43K Sell
1,344
-149
-10% -$4.62K ﹤0.01% 2615
2013
Q2 		$44K Buy
+1,493
New +$55.7K ﹤0.01% 2550

Other funds holding ANTH

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Jane Street's ANTH Position: Q4 2013 in Review

Jane Street sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2013, closing a stake of 1,344 shares — an estimated $43K sold.

Jane Street first reported a position in ANTH in Q2 2013 and held it in 2 quarters. The position peaked at $44K in Q2 2013. 33 funds tracked by Wall St. Rank hold ANTH as of Q4 2013.

  • Jane Street reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Jane Street sold 1,344 Anthera Pharmaceuticals, Inc. shares in Q4 2013, an estimated $43K.
  • Jane Street first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Jane Street's Anthera Pharmaceuticals, Inc. position peaked at $44K in Q2 2013.
  • 33 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2013.

Based on Jane Street's 13F filing for Q4 2013, filed 14 Feb 2014.